Loading clinical trials...
Loading clinical trials...
Falls and Cardiovascular Events in Elderly Patients With Sinus Node Disease Treated With a MVPTM Pacemaker According to the ESC 2007 Guidelines
The purpose of this study is to document the number of falls and fractures in Sinus Node Disease (SND) patients.
The purpose of this study is to compare the number of falls and fractures in Sinus Node Disease (SND) patients before versus after implantation of a MVP (TradeMark) pacemaker. Further the effect of pacing in the MVP (TradeMark) mode in respect of cardiovascular events is going to be analyzed in the same population.
Age
50 - No limit years
Sex
ALL
Healthy Volunteers
No
Zuger Kantonsspital
Baar, Switzerland
University Hospital Basel
Basel, Switzerland
SG Spitalregion RWS
Kanton Sankt Gallen, Switzerland
Kantonsspital St. Gallen
Sankt Gallen, Switzerland
CHCVS - Hôpital de SION
Sion, Switzerland
Luzerner Kantonsspital
Sursee, Switzerland
Stadtspital Waid
Zurich, Switzerland
USZ - University Hospital Zurich
Zurich, Switzerland
Start Date
August 1, 2009
Primary Completion Date
January 1, 2014
Completion Date
January 1, 2014
Last Updated
July 3, 2025
87
ACTUAL participants
Fill out Questionnaire
OTHER
Lead Sponsor
Medtronic Cardiac Rhythm and Heart Failure
NCT07221682
NCT03008291
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07290595